HSP90 targeting in cancer treatment started with natural inhibitor, geldanamycin (GM) (Figure 9(AI)), which was derived from Streptomyces hygroscopicus and exhibits potent antiproliferative activity via binding to the ATP-binding site of HSP90 to prevent its function [251,252]. Here, HSP90AA1 is linked to cancer.